Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPodiatryAetna Foot Orthotics Coverage & Prior Auth | OpenP…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentAetnaPolicy 0451

    Foot Orthotics

    Customize your policy alerts

    Sign up for Aetna Policy 0451 alerts

    Get alerted when Policy 0451 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, coverage limits, exclusions, and coding guidance for foot orthotics, therapeutic diabetic shoes, prosthetic shoes, and related modifications for Aetna members.

    Policy Summary
    PayerAetna
    PolicyFoot Orthotics
    Policy CodePolicy 0451
    Change TypeNo material changes
    Effective DateOct 4, 2000
    Last ReviewFeb 16, 2023
    Next Review DateApr 25, 2024
    Key ActionDocument clinical justification and provide prescription/fitting details (casts, measurements, trial fittings) when requesting custom-made orthopedic shoes or advanced orthoses.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1 paircustom-molded shoes allowed per calendar year (plus inserts)
    1–2 yrstypical refurbishing interval for orthotics
    1 per footmaximum considered medically necessary
    Diabetic benefittherapeutic shoes covered when diabetes criteria met
    20+ rangesICD-10 code ranges listed
    04/25/2024next scheduled review

    Coverage Criteria

    General medical necessity — Orthosis (foot orthotics) and/or prosthesis

    Orthosis (foot orthotics) and/or prosthesis considered medically necessary when ALL of the following are met:

    General criteria: Care is prescribed by a physician, nurse practitioner, podiatrist or other health professional qualified to prescribe orthotics/prosthetics according to state law; AND the orthosis or prosthesis will significantly improve or restore physical functions required for mobility related activities of daily living (MRADLs); AND the participating physician or licensed health care practitioner has determined by physical examination that the device will allow the member to perform activities of daily living (ADLs); AND the orthosis or prosthesis is provided within six months of the date of prescription; AND the orthotic or prosthetic services are performed by a duly licensed and/or certified, if applicable, orthotic and/or prosthetic provider; AND the services provided require the complexity and nature to be provided by a licensed or certified professional orthotist and/or prosthetist or under their direct supervision; AND the certified professional orthotist or prosthetist must be in good standing with ABC, BOC, or be state licensed where required.

    Therapeutic diabetic shoes

    Therapeutic shoes (depth or custom-molded) and inserts are medically necessary for members with diabetes mellitus when ANY of the following diabetic foot complications are present (and member has an eligible plan):

    Policy Summary
    PayerAetna
    PolicyFoot Orthotics
    Policy CodePolicy 0451
    Change TypeNo material changes
    Effective DateOct 4, 2000
    Last ReviewFeb 16, 2023
    Next Review DateApr 25, 2024
    Key ActionDocument clinical justification and provide prescription/fitting details (casts, measurements, trial fittings) when requesting custom-made orthopedic shoes or advanced orthoses.
    SourceLink
    On This Page
    Coverage CriteriaCodingProvider Actions and AuthorizationDefinitionsBackgroundRevision History
    Diabetic foot complications (ANY): Foot deformity; OR history of pre-ulcerative calluses; OR history of previous ulceration; OR peripheral neuropathy with evidence of callus formation; OR poor circulation; OR previous amputation of the foot or part of the foot.

    Must be a diabetic member with an eligible plan/benefit.

    Quantity limits: Per member per calendar year: EITHER no more than 1 pair of custom-molded shoes (including inserts provided with the shoes) plus 2 additional pairs of inserts; OR no more than 1 pair of depth shoes plus 3 pairs of inserts (not including non-custom removable inserts provided with such shoes).per calendar year

    Deluxe features (A5508) are restricted to diabetic benefit and considered experimental when criteria not met.

    Shoe characteristics: Depth shoes: available in full and half sizes with a minimum of 3 widths, made of leather or equivalent material, with a full-length heel-to-toe removable filler providing at least 3/16 inch additional depth, and have a closure; Custom-molded shoes: constructed over a positive model of the member’s foot, have removable inserts, have a closure, and are made of leather or equivalent.

    Depth or custom-molded shoes without these characteristics have no proven value for diabetes.

    Non-exclusion plan medical necessity

    For plans that do not exclude coverage of foot orthotics, orthotics are medically necessary when ALL of the following are met:

    Selection criteria: 1) Member has one or more of the listed conditions (adults: e.g., acute or chronic plantar fasciitis; acute sport-related injuries; calcaneal bursitis/spurs; chronic ankle instability; diabetes-related conditions; inflammatory foot conditions; medial knee osteoarthritis; musculoskeletal/arthropathic deformities impairing walking such as bunions, hallux valgus, hammertoes; neurologically impaired feet including neuropathies; vascular conditions including ulceration or poor circulation; children: hallux valgus, in-toe/out-toe gait, musculoskeletal weakness, structural deformities, torsional conditions); AND 2) the member has symptoms associated with the particular foot condition (asymptomatic conditions are not medically necessary); AND 3) the member has failed to respond to a course of appropriate conservative treatment (e.g., physical therapy, injections, strapping, anti-inflammatory medications).

    Orthotics are not first-line therapy; experimental for joint hypermobility syndrome.

    Device types, replacements, and limits

    Types of orthotics/shoes considered medically necessary (when clinical criteria are met) and limits on replacement:

    Covered device types: Shoe modifications to standard non-orthopedic shoes (e.g., rocker soles, buildups, metatarsal bars); over-the-counter standard orthopedic Oxford shoes when the foot can be accommodated; inlay shoes; depth inlay/depth shoes meeting diabetic shoe criteria; healing/cast shoes (short-term); molded shoes; custom-made orthopedic shoes when lesser means cannot accommodate the condition or leg length discrepancy >= 1.5 inches; and modifications of custom-made/molded/depth shoes.

    Over-the-counter orthotics are medically necessary only for short-term acute use and are not appropriate for children.

    Replacement and refurbishing: Replacement or modification is medically necessary based on the same criteria as the original device (e.g., worn out or loss of effectiveness); orthotics may need refurbishing periodically (typically every 1–2 years) but are generally not necessary more often than every 2 years; only 1 orthotic per foot is considered medically necessary; separate orthotics for each pair of shoes are not considered medically necessary; orthotic devices made on the same date as an open cutting surgical procedure are not medically necessary.every ~1-2 years

    Replacement must be based on necessity, not convenience or style.

    Experimental / investigational

    The following are considered experimental and investigational (effectiveness not established):

    Experimental/investigational items: AposTherapy (biomechanical shoe-like device); Orpyx sensory insoles for reduction of diabetic foot ulcer recurrence; Spinal Pelvic Stabilizers (Foot Levelers, Inc.); UNFO‑S (adductus-positioning device) for metatarsus adductus/varus; and other specialized devices without demonstrated effectiveness.

    These approaches are considered experimental/investigational because effectiveness has not been established.

    Custom-made orthopedic shoes - implied coverage conditions

    Custom-made orthopedic shoes may be necessary when ALL of the following are met:

    Custom shoe necessity: A physician or podiatrist determines that the severity of the foot condition is such that lesser means (e.g., inlay shoes, shoe modifications) cannot adequately compensate; AND there is a leg length discrepancy of at least 1.5 inches (>= 1.5 inches).leg discrepancy >= 1.5 inches

    Initial custom-made shoes, lasts, and patterns normally require the physical presence of the member for casts, measurements, and possible trial fittings.

    Types of orthoses covered when clinically indicated

    Foot orthoses may be:

    Accommodative orthoses: Custom or non-custom inlays fabricated to provide relief from callosities and pressure points and to maintain the integrity of the longitudinal arch and/or metatarsal heads (accommodative orthoses).

    Typically used for pressure relief, diabetic/ischemic or arthritic feet; may require more frequent replacement if soft materials used.

    Functional orthoses: Foot plates fabricated from plaster molds or electronic imaging in a semi-weight bearing or non-weight bearing neutral position with corrections built in to prevent abnormal compensation during the gait cycle (functional orthoses).

    Used to address gait mechanics and provide structural support; materials may be semi-rigid or rigid.

    Indications for foot orthoses

    Covered when clinically indicated as described:

    General indications: Orthoses are indicated to relieve pressure on painful, ulcerated, scarred, or callused areas; to support weak or flat longitudinal or transverse arches; and to control foot position and affect alignment of other lower limb joints to improve foot function, control motion, reduce shock, and minimize stress forces that could cause deformity and pain.

    Devices may be commercially available or custom-made; selection depends on clinical presentation.

    Evidence summaries relevant to coverage

    Background evidence summaries and implications for coverage decisions (contextual findings rather than prescriptive coverage rules):

    Low back pain evidence: Evidence for foot orthotics treating low back pain is limited; due to lack of sufficient high-quality randomized controlled trials, orthotics for LBP may be considered experimental, though biomechanical rationale and pilot/pending RCTs exist.

    Implication: coverage may be restricted or require stronger evidence/documentation.

    Chronic ankle instability: Moderate evidence (including 1 RCT and 1 outcomes study) supports use of foot orthotics to improve postural control in chronic ankle instability; orthotics may be considered as a treatment option alongside conservative measures (e.g., external supports, taping, strengthening, proprioceptive training).

    Consider documentation of prior conservative measures.

    Ankle-foot orthoses indications: AFOs are commonly prescribed for muscle weakness affecting ankle/subtalar joints, deformity prevention/correction, and to reduce weight-bearing forces; custom AFOs are indicated for severe/permanent deficits while off-the-shelf devices may suffice for minor/temporary deficits.

    Custom devices may require prior authorization and documentation of severity and prior measures.

    Lateral wedge insoles for medial knee OA: Systematic reviews and trials generally show limited or inconsistent benefit of lateral wedge insoles (LWIs) versus neutral insoles for pain and function in medial compartment knee osteoarthritis, though some biomechanical improvements (reduced knee adduction moment or femoro-tibial angle) are reported; prescreening for biomechanical responders in trials produced small pain reductions in selected patients.

    Implication: routine prescription of LWIs for medial knee OA is not strongly supported and may require patient-specific justification or prescreening.

    AposTherapy and Orpyx evidence: Biomechanical footwear (AposTherapy) studies report improvements in pain, function, gait, and QOL in various cohorts though study designs vary and some lack controls; Orpyx Sensory Insoles showed reduced diabetic foot ulcer recurrence in a randomized proof-of-concept study, particularly among good compliers.

    Implication: novel devices may require robust supporting evidence and documentation of patient risk and adherence for coverage consideration.

    Evidence summary

    Summary of evidence-based findings relevant to coverage decisions (context and limitations):

    Biomechanical footwear and foot-worn devices: Randomized and nonrandomized studies report improvements in pain, function, and gait parameters and reductions in ulcer incidence for select populations with certain foot-worn biomechanical devices; however, results are heterogeneous, study quality varies, and long-term safety and effectiveness evidence and replication are often limited.

    When seeking coverage for such devices, provide device-specific RCT or high-quality evidence and clinical justification.

    Lateral wedge insole coverage evidence

    Summary of findings from systematic reviews and trials addressing lateral wedge insoles (LWIs) for medial compartment knee osteoarthritis:

    LWI general findings: Systematic reviews and meta-analyses generally show no statistically significant or clinically important improvement in pain or function for lateral wedge insoles compared with neutral or flat insoles in medial compartment knee osteoarthritis; some biomechanical improvements (e.g., femoro-tibial angle) have been reported.

    Penny et al (2013) and Zhang et al (2018) concluded limited/no benefit for pain/function; Zhang found improvement in femoro-tibial angle.

    Responder and subgroup findings: Trials that prescreened patients for biomechanical response (e.g., >=2% reduction in knee adduction moment) and excluded patellofemoral OA showed a small reduction in knee pain with LWIs versus neutral insoles, but effect sizes were small and of uncertain clinical significance.

    Felson et al (2019) found MD 0.7 on 0-10 pain scale in prescreened responders; clinical importance limited.

    Tailored LWI trials: A randomized trial of tailored LWIs adjusted by biomechanical analysis showed no significant between-group differences in pain, biomechanical parameters, or most functional outcomes after 12 weeks compared with neutral insoles, aside from minimal symptom differences without clinical significance.

    Ferreira et al (2021) n=38; tailored wedges 2–10 degrees; overall no clinically meaningful advantage over neutral insoles.

    Orthotic/shoe selection criteria

    Device selection depends on pathology severity and specific indications; the Appendix maps common pathologies to suggested shoe/orthotic types and insert modifications:

    Orthotic and shoe recommendations: Appendix guidance links forefoot, midfoot, and rearfoot pathologies (e.g., hallux deformities, Charcot foot, diabetic neuropathy, peripheral vascular disease, amputations) to suggested shoe types (standard orthopedic Oxford, Oxford-style boot, depth shoe, custom-molded) and insert modifications (OTC accommodation orthoses, semi-rigid/rigid functional orthosis, additional accommodative padding), with the note that shoe/orthotic type must be determined based on severity of pathology and preventive follow-up for diabetic/vascular patients.

    Adapted from VHA 2004; used to inform device selection and documentation.

    Most Aetna plans exclude coverage of orthopedic shoes, foot orthotics, and other supportive foot devices except in specific circumstances. Exceptions include when the shoe is integral to a covered leg brace (with expense included in the brace), therapeutic diabetic shoes furnished per applicable plan/mandate, rehabilitative orthotics prescribed as part of post‑surgical or post‑traumatic casting care, and prosthetic shoes. For plans that do not exclude foot orthotics, separate policy sections describe medical necessity criteria and covered device types.

    Providers should verify member benefits and applicable state diabetic shoe mandates because coverage depends on plan design. This exclusion aligns with CMS guidance and does not apply when the shoe or modification is considered an integral part of a covered brace, is medically necessary as part of post‑surgical rehabilitative care, or meets the therapeutic diabetic shoe criteria described elsewhere in the policy.

    Shoes that are billed separately (i.e., not billed as part of a brace) will not be covered even if they are later incorporated into a brace. When a shoe is covered as an integral part of a leg brace, the expense must be included in the overall brace billing; separate charges for a matching non‑attached shoe are not covered unless the shoe is specifically permitted by exceptions in the policy.

    When submitting claims, ensure footwear that functions solely as a brace component is billed as part of the brace; separately billed shoes risk denial under the policy exclusion for stand‑alone shoes and orthotics.

    The policy lists specific HCPCS and ICD‑10 codes that are not covered for the indications listed in this Clinical Policy Bulletin. Examples include HCPCS L3161 (Foot, adductus positioning device, adjustable) and ICD‑10 codes such as L84 (corns and callosities) and congenital metatarsus adductus codes Q66.221–Q66.229. A longer range of ICD‑10 codes are similarly identified in the CPB as not covered for the listed indications.

    Use the policy code tables and the member’s benefit plan to confirm coverage; submission of claims using explicitly not‑covered codes for excluded indications may result in denial.

    Certain uses and devices are identified in the policy as experimental, investigational, or unproven because effectiveness has not been established in the literature. Examples explicitly named include specialized custom molded inserts marketed as Spinal Pelvic Stabilizers (Foot Levelers, Inc.), the UNFO‑S adductus‑positioning device, and some branded biomechanical footwear technologies.

    The policy notes that for indications lacking sufficient high‑quality evidence—such as the UNFO‑S device for metatarsus adductus/varus or other novel devices—coverage may be withheld until supportive clinical data are available. Providers should supply RCTs or high‑quality evidence when seeking authorization for such devices.

    The use of foot orthotics for low back pain (LBP) is treated cautiously in the policy. The literature review concludes that the available evidence is limited and of insufficient quality to establish clinical effectiveness; consequently, foot orthotics for LBP may be considered experimental or investigational in the absence of stronger RCT data.

    Systematic reviews of foot orthoses for related conditions (for example, plantar heel pain) show variable and generally small effects with heterogeneous interventions; this evidence limitation underpins the policy’s position that orthotics are not first‑line therapy and supports the investigational classification for LBP applications.

    Specifically for low back pain, the policy references reviews concluding a lack of sufficient high‑quality randomized controlled trials to support use of foot orthotics. Given this evidence gap, prescriptions of orthotics for primary LBP are considered experimental or investigational until more definitive trial data are available.

    Providers requesting coverage for orthotics to treat LBP should be prepared to submit objective, high‑quality evidence demonstrating clinical benefit, as routine coverage is not supported by the current literature cited in the policy.

    The policy highlights an explicit lack of evidence regarding effectiveness for the UNFO‑S adductus‑positioning device used for pediatric metatarsus adductus/varus. Because robust clinical data are not available, the device may be considered experimental and not covered for the indications listed until supporting evidence demonstrates safety and effectiveness.

    This absence of validated clinical outcomes means requests for UNFO‑S should include clinical trial data or other high‑quality evidence to justify coverage; without such documentation, denials are possible under the policy’s investigational device provisions.

    UpToDate and systematic review evidence cited in the policy indicate that lateral wedge insoles are not routinely suggested for medial compartment knee osteoarthritis because trials and meta‑analyses generally show limited or no clinically important improvements in pain or function compared with neutral insoles.

    While lateral wedges can reduce medial knee loading biomechanically and selected prescreened biomechanical responders may experience small pain reductions, the overall evidence does not support routine prescription of lateral wedge insoles for medial knee OA without patient‑specific biomechanical data.

    Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and do not constitute offers of coverage or medical advice. The bulletin provides a general description of plan benefits and is not a contract; benefit determination remains subject to the member’s specific plan language and applicable state mandates.

    Providers and patients should consult the member’s benefit plan for definitive coverage decisions and follow payer procedures for prior authorization and claim submission as applicable.

    The policy summarizes that orthotics have no proven value for a number of conditions in routine practice—specifically back pain, knee pain (other than medial compartment osteoarthritis), pes planus (flat feet), pronation, corns and calluses, hip osteoarthritis, and lower leg injuries—and are considered not medically necessary when the foot condition is asymptomatic.

    For symptomatic conditions such as plantar heel pain, the evidence base is mixed with small effect sizes and heterogeneity among orthosis designs; these limitations inform the policy’s conservative stance and the requirement that orthotics be used after failure of appropriate conservative therapies.

    Orthotic devices that are fabricated or provided on the same date as an open cutting surgical procedure are not considered medically necessary under this policy. Replacement or new‑fabricated devices provided on the day of surgery are not eligible for coverage as separate, medically necessary orthotic services.

    When orthotic or shoe services are related to surgical care, providers should follow the rehabilitative orthotic provisions for post‑surgical casting care described in the policy and document medical necessity consistent with those exceptions.

    The policy reiterates specific ICD‑10 codes that are not covered for indications listed in the CPB. For example, codes for conditions such as corns and callosities (L84) and select congenital metatarsus adductus codes (Q66.221–Q66.229) are enumerated among the not‑covered diagnoses.

    Submitters should ensure diagnostic coding aligns with covered indications; use of codes explicitly listed as not covered for the CPB’s indications may result in claim denial.

    The policy describes limited clinical effectiveness evidence for many plantar and lower‑extremity conditions. For example, systematic reviews of foot orthoses for plantar heel pain show small and variable effects, heterogeneous interventions, and uncertainty about which orthosis designs are most effective. These evidence limitations support the policy’s restricted or conditional coverage decisions for many plantar conditions.

    Given the heterogeneous trial designs and small effect sizes, the policy requires that orthoses be used for symptomatic patients who have failed conservative care and that documentation support the chosen device type and intended functional benefit.

    Systematic reviews and meta‑analyses of lateral wedge insoles generally do not demonstrate strong or consistent benefit in pain or function when compared with neutral or flat insoles for medial compartment knee osteoarthritis. Trials that prescreened for biomechanical responders have shown small pain reductions in selected patients, but overall effects are limited.

    This body of evidence forms the basis for the policy’s position that routine prescription of lateral wedge insoles for medial knee OA is not supported without patient‑specific biomechanical justification.

    Coding

    Covered HCPCS/HCPT codes if selection criteria metHCPCSCovered
    A5500 - A5507, A5510 - A5514Diabetic shoes, fitting, and modifications.
    A9283Foot pressure off loading/supportive device, any type, each.
    L3000 - L3031Foot inserts, removable.
    L3040 - L3090Foot arch supports, removable or nonremovable.
    L3100 - L3170Repositioning foot orthotics.
    L3201 - L3265Orthopedic footwear (shoes, boots, depth inlays).
    L3300 - L3485Shoe modifications (lifts, wedges, heels).
    L3500 - L3649Other orthopedic shoe additions, and transfers.
    A5508Deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe (for diabetics only).
    Sample ICD-10 codes referenced (not all-inclusive)ICD-10
    E10.21 - E11.29 (various)Diabetes with complications (neurological, circulatory, kidney complications) — examples listed in policy.
    M17.0 - M17.12Primary osteoarthritis of knee (medial OA referenced).
    G57.00 - G57.93Mononeuropathies of lower limb.
    I70.201 - I70.299Atherosclerosis of native arteries of the extremities.
    L97.101 - L97.929Non-pressure chronic ulcer of lower limbs.
    Listed ICD-10 CodesICD-10
    E08.00 - E08.9Diabetes mellitus due to underlying condition
    E10.21 - E10.29
    E11.21 - E11.29
    E13.21 - E13.29
    E10.40 - E10.49Diabetes with kidney complications
    E11.40 - E11.49
    E13.40 - E13.49
    E10.51 - E10.59Diabetes with neurological complications
    E11.51 - E11.59
    E13.51 - E13.59
    1–10 of 86
    1/9
    HCPCS codes not covered for indications listedHCPCSNot Covered
    L3161Foot, adductus positioning device, adjustable
    ICD-10 codes not covered for indications listed in the CPBICD-10Not Covered
    L84Corns and callosities
    Q66.221 - Q66.229Congenital metatarsus adductus
    Descriptive device categories (no CPT/HCPCS codes listed in these chunks)mixed
    No codes listed
    Leg-length discrepancy threshold for custom shoes
    Leg-length discrepancy threshold>= 1.5 inches
    Interior heel wedge size range
    Interior heel wedge height range0.0625 to 0.125 inch

    Provider Actions and Authorization

    Prior Authorization

    PA may be required for listed HCPCS/HCPT codes

    Prior authorization may be required for the HCPCS/HCPT codes listed in the policy; these codes are covered only if the selection criteria in the policy are met.

    • Covered codes listed: A5500–A5507, A5510–A5514, A9283, L3000–L3031, L3040–L3090, L3100–L3170, L3201–L3265, L3300–L3485, L3500–L3649.
    • Coverage is conditional on meeting the clinical selection criteria in the policy.
    Prior Authorization

    Obtain custom shoes with member present for casts/fit

    Initial custom-made orthopedic shoes, lasts, and patterns are normally obtained when the severity of the foot disability requires the physical presence of the member for casts, measurements, and possible trial fittings.

    • Custom-made shoes are for gross deformities or leg shortening ≥ 1.5 inches.
    • Custom fabrication involves casts, measurements, and trial fittings with the member present.
    Note

    No explicit PA code-level rules in background sections

    The policy provides clinical indications and device descriptions but does not specify explicit code-level prior authorization requirements in the cited background sections.

    • Clinical indications and orthosis/device descriptions are detailed in the background.
    • No explicit prior authorization code-level rules are specified in these background excerpts.
    Prior Authorization

    Document need for custom AFO/KAFO; PA may be required

    Custom AFOs and KAFOs are indicated for more severe or permanent deficits; prior authorization may be required with documentation of functional deficits and prior conservative measures.

    • Inexpensive ready-to-use AFOs may suffice for minor/temporary deficits; custom-made orthoses are indicated for severe/permanent deficits.
    • Document the severity and prior conservative treatment when requesting custom AFO/KAFO.
    Prior Authorization

    Provide risk status and monitoring plan for intelligent insoles

    For intelligent insoles intended to reduce diabetic foot ulcer recurrence (e.g., Orpyx Sensory Insoles), documentation should include the patient’s high‑risk status (diabetes with peripheral neuropathy and prior plantar ulceration) and intended monitoring/adherence plan to justify use.

    • Orpyx Sensory Insoles were studied in patients with diabetes, peripheral neuropathy, and recent plantar ulceration, showing reduced ulcer incidence in that high‑risk group.
    • Document monitoring/adherence plan and patient risk factors when seeking authorization for such devices.
    Prior Authorization

    PA may require documentation of biomechanical response for lateral wedges

    Because evidence for lateral wedge insoles is limited and benefits may be confined to biomechanical responders, prior authorization could require documentation of biomechanical response (e.g., prescreening demonstrating a reduction in knee adduction moment) or other objective justification.

    • Felson et al. prescreened for biomechanical responders (≥2% KAM reduction) and found a small pain benefit in that subgroup.
    • UpToDate and systematic reviews report limited overall clinical benefit for lateral wedges, supporting prescreening documentation if seeking coverage.
    Note

    No explicit prior authorization stated in excerpts

    No explicit prior authorization requirements are specified in the policy excerpts provided.

    • Policy history and administrative sections do not state specific PA triggers in the cited text.
    Step Therapy

    Require failure of conservative treatments before orthotics

    Orthotics should not be first-line therapy; members must have failed appropriate conservative treatments (for example, physical therapy, injections, strapping, or anti‑inflammatory medications) before orthotics are considered.

    • Document prior conservative treatments and lack of response when requesting orthotics.
    • Orthotics are not considered medically necessary when the foot condition is asymptomatic.
    Step Therapy

    Attempt lesser measures before custom-made orthopedic shoes

    Use of lesser means (such as inlay shoes or shoe modifications) should be attempted before ordering custom-made orthopedic shoes when appropriate.

    • Custom-made shoes are appropriate only when lesser means cannot adequately compensate for the deformity or leg discrepancy ≥ 1.5 inches.
    • Document attempts at inlay shoes or shoe modifications when applicable.
    Note

    No formal step therapy protocol specified

    No formal step therapy rules are described in the cited policy excerpts.

    • The document notes conservative comparators and evidence but does not prescribe a step therapy protocol.
    Step Therapy

    Document prior conservative measures for chronic ankle instability

    For chronic ankle instability, consider and document prior use of external supports, taping, strengthening, and proprioceptive training alongside orthotic options before authorization of more advanced devices.

    • UpToDate recommends external supports, taping, stretching, strengthening, and proprioceptive ankle training as options for prevention and management.
    • Document prior conservative interventions when requesting orthotic authorization for CAI.
    Note

    Prefer conservative comparators before lateral wedge prescription

    Conservative measures (standard care, neutral insoles, or other noninvasive therapies) are commonly used comparators in studies; evidence does not clearly support lateral wedge insoles over neutral insoles for routine prescription.

    • Systematic reviews report no consistent benefit of lateral wedge insoles versus neutral insoles for pain or function in medial knee OA.
    • Consider conservative alternatives and document rationale if prescribing lateral wedges.
    Note

    No formal step therapy; document conservative care and selection rationale

    No explicit step therapy rules are provided in the policy excerpts; literature cited supports conservative use and suggests lateral wedges are not routinely recommended.

    • Providers should document conservative care and patient selection rationale when seeking coverage for interventions lacking routine support in evidence.
    Note
    Documentation Required

    Document exam showing device improves MRADLs/ADLs and timeframe

    Prescribing clinicians must document a physical examination showing that the orthosis/prosthesis will improve MRADLs and enable performance of ADLs; the device must be provided within six months of prescription and services performed by licensed/certified providers.

    • Documentation should demonstrate that the device will significantly improve or restore physical functions required for MRADLs and ADLs.
    • Services must be performed by a duly licensed/certified orthotic/prosthetic provider and provided within six months of the prescription.
    Documentation Required

    Include function, material, design, and fitting details on prescriptions

    Orthotic prescriptions should state the desired function, specific material, and specific design/construction; initial custom-made shoes require casts, measurements, and possible trial fittings.

    • Prescription must include function requested and device specifications (material, design).
    • Record casts, measurements, and trial fitting details for custom-made shoe requests.
    Documentation Required

    Document clinical justification and selected device specifications

    Documentation should support the specific clinical indication for the orthosis (for example, painful, ulcerated or callused areas; weak or flat arches; deformity requiring correction) and the type/material selected (soft, semi‑rigid, rigid) as described in the background.

    • Provide clinical findings and rationale linking the chosen orthosis type/material to the patient’s impairment.
    • Tie device selection to the policy’s stated indications (pressure relief, support, alignment control).
    Documentation Required

    Provide impairment-specific clinical justification and goals

    Clinical justification for device requests should document the specific impairment (for example, dorsiflexor/plantarflexor weakness, deformity requiring prevention/correction, or need for immobilization/offloading) and the functional goals given variability in device designs.

    • State the impairment, functional deficits, and how the orthosis will address those goals.
    • Specify device type (AFO, metal AFO, KAFO, fracture orthosis) consistent with the clinical picture.
    Documentation Required

    Provide device-specific trial evidence for novel devices

    When requesting authorization for novel or device-specific therapies (for example, AposTherapy or Orpyx insoles), provide randomized trial evidence or device-specific study reports to demonstrate clinical benefit.

    • Reichenbach et al. (2020) and Abbott et al. (2019) are cited as device-specific trials supporting benefit in select populations.
    • Include study summaries and applicability to the member when available.
    Documentation Required

    Use appendix mapping to justify shoe/orthotic selection and follow-up

    Use the appendix selection table to document the shoe/orthotic type and insert modifications chosen based on pathology severity, and note recommended follow-up for preventive groups (e.g., diabetic neuropathy, peripheral vascular disease).

    • Map the member’s pathology to the appendix recommendations (shoe type and insert modifications) in documentation.
    • Document follow-up plans for preventive monitoring when applicable.
    Denial Risk

    Denial risk: missing qualified prescriber, timeframe, or licensure

    Failure to have care prescribed by a qualified prescriber, to provide services within six months of the prescription, or to have services performed by duly licensed/certified providers may trigger claim denial.

    • Ensure prescriber is authorized to prescribe orthotics per state law.
    • Provide devices within six months of the prescription and ensure licensed/certified orthotic/prosthetic providers perform services.
    Denial Risk

    Denial risk: billing codes explicitly listed as not covered

    Certain HCPCS and ICD‑10 codes are explicitly listed as not covered for the indications in this policy (for example, HCPCS L3161 and ICD‑10 L84 and Q66.221–Q66.229); billing these codes for excluded indications may result in denial.

    • HCPCS not covered example: L3161 (foot, adductus positioning device, adjustable).
    • ICD‑10 not covered examples: L84 (corns and callosities); Q66.221–Q66.229 (congenital metatarsus adductus).
    Denial Risk

    Denial risk: orthotics for low back pain considered experimental

    Use of foot orthotics for low back pain may be considered experimental or unproven due to lack of sufficient high‑quality randomized controlled trials and could be denied if strong RCT evidence is required.

    • Policy notes the evidence gap for LBP and classifies orthotics as experimental/investigational for LBP until stronger RCT data are available.
    • Provide higher-quality evidence if seeking coverage for LBP indications.
    Denial Risk

    Denial risk: novel devices lacking sufficient evidence

    Insufficient clinical validation or lack of evidence for novel devices (for example, UNFO‑S) may trigger coverage denial or requests for additional documentation.

    • UNFO‑S lacks evidence of effectiveness per the policy background.
    • For intelligent insoles, provide study data and applicability; lack of validation may prompt denial or further information requests.
    Note
    Note
    Note
    Note

    Definitions

    Depth shoe definition
    DefinitionDepth shoe: a shoe with a full-length, heel-to-toe filler that, when removed, provides a minimum of 3/16 inch of additional depth; has closure; may have an internally seamless toe; used to accommodate custom-molded or customized inserts.
    Custom-molded shoe definition
    DefinitionCustom-molded shoe: constructed over a positive model of the member’s foot, with removable inserts that can be altered or replaced as the member’s condition warrants; includes a closure and is made of leather or equivalent material.
    Accommodative foot orthoses definition
    DefinitionAccommodative foot orthoses: custom or non-custom inlays fabricated to provide relief from callosities and pressure points and to maintain the integrity of the longitudinal arch and/or metatarsal heads.
    Materials/UseTypically soft or flexible materials (leather, cork, rubber, soft plastics) and used to absorb shock, increase balance, and offload ulcerated or painful areas.
    GoalProvide pressure relief and protect insensitive, ischemic, or ulcerated feet, often used in diabetes and arthritic conditions.
    Functional foot orthoses definition
    DefinitionFunctional foot orthoses: foot plates fabricated from plaster molds or electronic imaging in a semi-weight bearing or non-weight bearing neutral position with corrections built in to prevent abnormal compensation during the gait cycle.
    ConstructionMolded to measurements/plaster models of the foot and leg; materials include semi-rigid or rigid plastics to control motion and support arches.
    IndicationIntended to address gait mechanics and reduce abnormal compensation during walking.
    Custom-made orthopedic shoes definition
    DefinitionCustom-made orthopedic shoes: shoes fabricated over special modified lasts per prescription to accommodate gross foot deformities or leg shortening of at least 1.5 inches; initial fabrication normally requires the member’s presence for casts, measurements, and possible trial fittings.
    PurposeUsed to prevent or correct disorders of bones, joints, muscles, ligaments and cartilage of the legs and feet when lesser means cannot compensate.
    Shoe modification definition
    DefinitionShoe modification: medically prescribed alteration(s) to a shoe to accommodate minor foot deformities or leg shortening less than 1.5 inches (e.g., rocker soles, buildups, metatarsal bars, Thomas heels, tongue pads, velcro closures, modified lacers).
    ApplicationMay be applied to personally purchased shoes when medically indicated; payment for modifications may be limited relative to insert allowances.
    TypesIncludes internal modifications (inserts, pads, interior heel lifts) and external modifications (sole/heel attachments, external elevations >0.25 inch).
    Internal vs external shoe modifications definition
    ContrastInternal modifications: inserted inside the shoe or sandwiched between shoe components (e.g., shanks, pads, interior heel lifts).
    ContrastExternal modifications: attached to the sole or heel (e.g., external elevations/lifts, bars, sole or heel additions).
    NoteElevations greater than 0.25 inch are typically placed externally; interior heel wedges range 0.0625–0.125 inch.
    Wedge (shoe) definition
    DefinitionWedge (shoe): any device, generally constructed of leather, placed on the side of the walking surface or within shoe construction (not in direct contact with the foot) to redistribute weight through the foot.
    TypesIncludes first metatarsal head, full lateral, full medial, lateral Dutchman, medial Dutchman, medial tip; used to shift body weight and provide rotatory stability.
    PurposeRedistributes load across the foot to offload painful or deformed regions and adjust foot alignment.
    Foot orthoses definition
    DefinitionFoot orthoses: mechanical devices placed in a shoe (inserts) to restore/maintain foot alignment, relieve stress from soft tissues or bony prominences, support arches, and control foot position; available commercially or custom-made.
    MaterialsSoft, semi-rigid, or rigid materials (leather, cork, rubber, plastics, metal plates) depending on intended function.
    IndicationsRelieve pressure on painful, ulcerated, scarred or callused areas; support weak/flat arches; control foot position and affect lower limb joint alignment.
    Splints (Mechanical Bars) definition
    DefinitionSplints (Mechanical Bars): mechanical devices attached to special shoes consisting of an adjustable or stationary bar between shoes to control position and motion for correcting foot deformities (examples: Dennis-Brown, Brachman, Filauer, Friedman, Gottler, night splints).
    TypesIncludes movable (Brachman), non-movable (Dennis-Brown), and adjustable rotation versions (Filauer); night splints are used therapeutically (e.g., plantar fasciitis).
    Ankle-foot orthosis (AFO) definition
    DefinitionAnkle-foot orthosis (AFO): a device prescribed for ankle/subtalar muscle weakness or deformity prevention that may be plastic (footplate, upright component, Velcro calf strap) or metal (medial/lateral uprights with ankle joint and stirrup attachment); plastic AFOs are worn inside the shoe.
    IndicationUsed to prevent/correct deformities, reduce weight-bearing forces, and influence knee stability via ankle position.
    Hip-knee-ankle-foot orthosis (HKAFO) definition
    DefinitionHip-knee-ankle-foot orthosis (HKAFO): an orthosis comprising AFO/KAFO components plus an attached lockable hip joint and a pelvic band to control hip movement.
    ComponentsIncludes AFO/KAFO elements with additional hip-level control (lockable hip joint, pelvic band).
    Fracture orthosis definition
    DefinitionFracture orthosis: an orthosis permitting controlled mobilization around a fracture, typically including a cylinder that fits the limb, a footplate worn inside the shoe, and a joint mechanism connecting components to allow progressive weight bearing.
    UseUsed when internal fixation is unnecessary, contraindicated, refused, or healing is delayed; allows functional ambulation with progressive loading.
    AposTherapy definition
    DefinitionAposTherapy: a non-invasive, individualized foot-worn biomechanical device and treatment methodology intended to alter the center of pressure and gait moments to reduce pain and improve function (commonly used for knee OA).
    DeliveryDevice is individually calibrated and used during daily activities with monitoring of gait, pain, and function; may include adjustable convex pods under the outsole.
    Evidence noteStudies report short- and long-term improvements in pain, function, gait parameters and QOL, though some trials are non-randomized or have limitations.
    Orpyx Sensory Insoles (SI) definition
    DefinitionOrpyx Sensory Insoles (SI): FDA-registered custom insoles that measure and provide real-time feedback on plantar temperature, pressure, and adherence for patients (used to monitor and potentially reduce diabetic foot ulcer risk).
    FunctionProvide continuous plantar monitoring and feedback to support ulcer prevention strategies in high-risk diabetic patients.
    UNFO‑S definition
    DefinitionUNFO-S: an adductus-positioning orthopedic device worn below the ankle intended to correct metatarsus adductus/varus in pediatric patients by stabilizing the heel and applying corrective pressures to the mid-foot; evidence of effectiveness is lacking.
    RolePresented as an alternative to serial casting for infant/adolescent metatarsus adductus/varus, but current evidence is insufficient.
    AposTherapy (biomechanical footwear) definition
    DefinitionAposTherapy (biomechanical footwear): shoe-like devices with adjustable convex pods or external pods under the outsole intended to alter center of pressure and train neuromuscular control to reduce symptoms and improve gait in knee OA and related conditions.
    UsageIndividually calibrated, used during daily activities for short periods to retrain gait; evidence includes randomized and nonrandomized studies with mixed certainty.
    Lateral wedge insole (LWI) definition
    DefinitionLateral wedge insole (LWI): an in-shoe lateral wedge intended to alter tibiofemoral alignment and reduce medial knee loading in medial compartment knee osteoarthritis.
    MechanismAims to reduce knee adduction moment and femoro-tibial angle; effect on pain/function is inconsistent across trials and reviews.
    Biomechanical responder definition
    DefinitionBiomechanical responder: a patient who demonstrates a measurable reduction in knee adduction moment (e.g., ≥2% reduction) when wearing a wedge on gait analysis; used as a prescreen to identify likely beneficiaries in trials.
    ContextPrescreening for biomechanical response was used in at least one RCT and may identify subgroups with small reductions in knee pain when using LWIs.

    Background

    Foot orthotics and therapeutic shoes are used to improve mobility, accommodate or correct deformities, offload pressure, and address diabetic foot complications. Orthotics can be accommodative (pressure relief and arch support) or functional (fabricated with corrections to address gait mechanics); therapeutic diabetic shoes have defined features and are limited to diabetic members meeting specified foot complication criteria.

    Revision History

    2000-10-04policy_effective

    Policy became effective.

    2023-02-16last_reviewLatest

    Policy was last reviewed.

    2024-04-25next_scheduled_review

    Next scheduled policy review date.